Hello, Fool! | Login | Signup | My Fool
Oct 11, 2008 11:12 AM ET | Feedback | Site Changes | Help
A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer.
View Ticker Page (CEGE)
Results 31 - 40 of 56 : 12345Next »
Recs
plumswamp (79.23) Submitted: 11/18/06 1:37 AM : Start Price: $4.56 CEGE Score: 51.78
Nothing new..................
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
kripalan (< 20) Submitted: 11/30/06 2:46 PM : Start Price: $3.90 CEGE Score: -49.42
Good drugs in the pipeline. When they get FDA approval, the stock will rocket.
LionShare4jp (20.04) Submitted: 4/15/08 10:07 AM : Start Price: $3.09 CEGE Score: -49.55
A Cure for Cancer? It's unlikely, but any new treatments that would improve patient survivall would be a good start.Competes with DNDN Provenge, and Provenge did miss it's endpoints.
7dogs (99.46) Submitted: 4/17/08 1:44 PM : Start Price: $3.31 CEGE Score: -49.18
GVAX candidate has Fast Track status granted May 2006 by FDA for immunotherapy for prostate cancer and currently conducting two Phase-III trials of GVAX. Possible that red ink could turn black. Outperform.
YoungInvestor99 (76.27) Submitted: 4/22/08 9:29 PM : Start Price: $3.80 CEGE Score: -50.56
Equity in this company has dropped many millions every year, it is down to 37 million and it does not look like it will be much longer before they are finished.
Report this Post Replies: 2 | Reply | Permalink
Marauder03 (< 20) Submitted: 4/25/08 11:51 AM : Start Price: $3.87 CEGE Score: -50.45
Prostate cance is #1 cancer in men, for now...
Money2themax (62.57) Submitted: 5/07/08 12:28 AM : Start Price: $3.74 CEGE Score: 48.44
IF full FDA approval happens for the cancer-fighting drug that is currently in Stage III Trials, this stock launches and never looks back! However, FDA approval timing is unpredictable so look for this stock to be in the doldrums for awhile yet.
RhoWidget (< 20) Submitted: 5/11/08 9:23 AM : Start Price: $3.98 CEGE Score: -50.49
FDA approval for GVAX by 2nd quarter CY09.
ks4rate (< 20) Submitted: 7/10/08 10:16 AM : Start Price: $2.50 CEGE Score: -50.67
New developments and improvement.
mattjetfan (< 20) Submitted: 8/11/08 11:53 PM : Start Price: $3.09 CEGE Score: -51.08
NIce stock. Very Very Volatile, hopefully will continue to climb.
Terms & Conditions
RSS Headlines
Fool UK